Testing effectiveness (Phase 2)Ended earlyNCT03866187
What this trial is testing
Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection
Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 236